Abstract
Purpose
Vaccinations are essential in minimizing the effects of global health crises including COVID-19 pandemic. This study investigates the potential association between COVID-19 vaccination and the occurrence of medium vessel vasculitis.
Methods
Several databases were utilized to conduct a comprehensive literature review. The studies were carefully evaluated to ensure their quality and eliminate any potential bias.
Results
After reviewing 935 search results and removing duplicates, we selected 10 case reports. We discovered that medium vessel vasculitis may occur after COVID-19 vaccination, typically appearing around 16.2 days after vaccination. The patients in the study had a median age of 43.5 years and were predominantly males (80%). Additionally, half of the cases were reported after the second dose of vaccination.
Conclusions
Vaccination-associated vasculitis is a rare yet possible complication of COVID-19 vaccination and lacks a clear treatment protocol.
Similar content being viewed by others
Data availability
Data supporting the findings of this study are available within the article as supplementary materials.
References
Savage CO, Harper L, Cockwell P, et al. ABC of arterial and vascular disease: vasculitis. BMJ. 2000;320:1325–8.
Dillon MJ, Eleftheriou D, Brogan PA. Medium-size-vessel vasculitis. Pediatr Nephrol. 2010;25:1641–52.
Kim DS. Kawasaki disease. Yonsei Med J. 2006;47:759–72.
Wong K, Farooq Alam Shah MU, Khurshid M, et al. COVID-19 associated vasculitis: A systematic review of case reports and case series. Ann Med Surg (Lond). 2022;74:103249.
Gagnier JJ, Kienle G, Altman DG, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. Glob Adv Health Med. 2013;2:38–43.
Peralta-Amaro AL, Tejada-Ruiz MI, Rivera-Alvarado KL, et al. Atypical Kawasaki Disease after COVID-19 vaccination: a new form of adverse event following immunization. Vaccines (Basel). 2022;10:126.
Ahmer S, Bourke J, Ardakani NM. Transient cryoglobulinaemic vasculitis following ChAdOx1 nCoV-19 vaccine. BMJ Case Rep. 2022;15:e250913.
Aebi C, Schöbi N, Duppenthaler A, et al. A case of adult-onset Kawasaki disease in an adolescent occurring during the COVID-19 pandemic. J Pediatr Infect Dis. 2023;18:107–12.
Makiyama A, Abe Y, Furusawa H, et al. Polyarteritis nodosa diagnosed in a young male after COVID-19 vaccine: a case report. Mod Rheumatol Case Rep. 2023;8:125–32.
Ohkubo Y, Ohmura SI, Ishihara R, et al. Possible case of polyarteritis nodosa with epididymitis following COVID-19 vaccination: a case report and review of the literature. Mod Rheumatol Case Rep. 2023;7:172–6.
Al-Allaf AW, Razok A, Al-Allaf Y, et al. Post-COVID-19 vaccine medium-vessel vasculitis and acute anterior uveitis, causation vs temporal relation; case report and literature review. Ann Med Surg (Lond). 2022;75:103407.
Mehrabi Nasab E, Athari SS. Reporting complete heart block in a patient with polyarteritis nodosa after COVID-19 vaccination. ESC Heart Fail. 2023;10:1418–21.
Showers CR, Maurer JM, Khakshour D, et al. Case of adult-onset Kawasaki disease and multisystem inflammatory syndrome following SARS-CoV-2 vaccination. BMJ Case Rep. 2022;15:e249094.
Srichawla BS. Polyarteritis nodosa following mRNA-1273 COVID-19 vaccination: case study and review of immunological mechanisms. Cureus. 2023;15:e33620.
Ohmura SI, Ohkubo Y, Ishihara R, et al. Medium-vessel vasculitis presenting with myalgia following COVID-19 moderna vaccination. Intern Med. 2022;61:3453–7.
Paules CI, Marston HD, Fauci AS. Coronavirus infections-more than just the common cold. JAMA. 2020;323:707–8.
Ksiazek TG, Erdman D, Goldsmith CS, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348:1953–66.
ECDC technical report: Interim guidance for environmental cleaning in non-healthcare facilities exposed to SARS-CoV-2, 2020
El-Shitany NA, Harakeh S, Badr-Eldin SM, et al. Minor to moderate side effects of Pfizer-BioNTech COVID-19 vaccine among Saudi residents: a retrospective cross-sectional study. Int J Gen Med. 2021;14:1389–401.
Riad A, Pokorná A, Attia S, et al. Prevalence of COVID-19 vaccine side effects among healthcare workers in the Czech Republic. J Clin Med. 2021;10:1428.
Watanabe Toru. Vasculitis following influenza vaccination: a review of the literature. Curr Rheumatol Rev. 2017;13:188–96.
Chen Y, Xu Z, Wang P, et al. New-onset autoimmune phenomena post-COVID19 vaccination. Immunology. 2022;165:386–401.
Segal Y, Shoenfeld Y. Vaccine-induced autoimmunity: the role of molecular mimicry and immune cross reaction. Cell Mol Immunol. 2018;15:586–94.
Mouliou DS, Dardiotis E. Current evidence in SARS-CoV-2 mRNA vaccines and post-vaccination adverse reports: knowns and unknowns. Diagnostics (Basel). 2022;12:1555. https://doi.org/10.3390/diagnostics12071555.
Author information
Authors and Affiliations
Contributions
Vivek Sanker: study concept, study design, data collection, data analysis, data interpretation, writing the paper. Maneeth Mylavarapu: study concept, data collection, data analysis, writing the paper. Prakash Gupta: study concept, data collection, data analysis, writing the paper. Naureen Syed: study concept, data analysis, writing the paper. Maitri Shah: study concept, data collection, data analysis, writing. Vamshi Krishna: study concept, data analysis, data interpretation, writing.
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflict of interests to declare.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sanker, V., Mylavarapu, M., Gupta, P. et al. Post COVID-19 vaccination medium vessel vasculitis: a systematic review of case reports. Infection (2024). https://doi.org/10.1007/s15010-024-02217-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s15010-024-02217-w